Steven H. Rouhandeh, Director, 10% Owner at PLASMATECH BIOPHARMACEUTICALS INC (PTBI), bought 13,375,024 shares at $4.00 ($53.5M) on 2014-12-24, disclosed to the SEC on 2014-12-29.
Open-market purchase of $53.5M PTBI by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 65,280 | $261K | 0.5% |
| 2 | $4.00 | 216,718 | $867K | 1.6% |
| 3 | $4.00 | 250,000 | $1.0M | 1.9% |
| 4 | $4.00 | 385,725 | $1.5M | 2.9% |
| 5 | $4.00 | 693,051 | $2.8M | 5.2% |
| 6 | $4.00 | 831,836 |
| $3.3M |
| 6.2% |
| 7 | $4.00 | 1,703,362 | $6.8M | 12.7% |
| 8 | $4.00 | 4,306,950 | $17.2M | 32.2% |
| 9 | $4.00 | 4,922,102 | $19.7M | 36.8% |
| Total | $4.00 avg | 13,375,024 | $53.5M | 100% |
| Filing → |
| ABEO | SELL | 2021-02-10 | $722K | — | Filing → |
| ABEO | SELL | 2021-01-19 | $1.3M | — | Filing → |
| ABEO | SELL | 2020-09-17 | $4K | — | Filing → |